Deep Tech Startups
5,913 companies tagged Deep Tech, with their investors and founders.
Transformer Lab operates a machine learning and AI research lab and builds tools for researchers, including a workbench to train, tune, evaluate, and inspect models across modalities, plus orchestration of distributed jobs across cloud providers like RunPod, Lambda, AWS, Azure, and GCP. It publishes open research and partners with academic and industry labs to accelerate the research workflow.
2 investors
Trestle Biotherapeutics develops bioengineered implantable tissues designed to treat end-stage renal disease, aiming to get patients off dialysis and eventually provide replacement organs. The company uses stem cell biology, biofabrication, and 3D bioprinting technologies to create functional kidney tissue for patients with kidney failure.
2 investors
Triditive develops the AMCELL platform, an automated 3D printing industrial machine that produces products with polymers and metals to address supply chain challenges. The company provides additive manufacturing solutions for manufacturing and production problems.
2 investors
Trillion Labs develops specialized foundation models designed to build and operate the physical infrastructure β energy, chips, and facilities β of AI factories that train AI. The models are aimed at automating and improving the operation of AI data center infrastructure.
2 investors
Lumentum designs and manufactures optical and photonic technologies for AI, data centers, telecommunications, industrial manufacturing, and sensing applications. The company produces optical communications components, lasers, and 3D sensing products that enable high-speed data movement and connectivity across cloud infrastructure and networks.
2 investors
Trince is a Ghent University spin-off developing photoporation technology for physical transfection of cells as an alternative to viral vectors and electroporation. Its technology, including the Lumipore platform, targets R&D, manufacturing, and GMP-compliant clinical applications such as cell and gene therapy.
2 investors
Trisk Bio develops scalable preclinical manufacturing processes for AAV (adeno-associated virus) gene therapies, offering bespoke production, purification, and process optimization services. It serves gene therapy developers and preclinical research teams in the biotech industry.
2 investors
Trogenix develops precision gene therapies for cancer using its Odysseus platform and Synthetic Super-Enhancer (SSE) technology, engineered DNA elements activated only in diseased cell states to selectively target and kill tumour cells while triggering an immune response. Its pipeline targets solid tumours, including a Phase I/II gene therapy (TGX-007) for glioblastoma, with potential applications in regenerative medicine.
2 investors
TrustPoint is building a commercial Global Navigation Satellite System (GNSS) using a C-Band LEO microsatellite constellation to deliver more accurate, secure, and jam- and spoof-resistant positioning, navigation, and timing services. It serves commercial and government users across automotive, aviation, critical infrastructure, and national security, with a focus on autonomous navigation applications.
2 investors
Trustworthy AI develops software to accelerate the development, testing, and deployment of safety-critical autonomous systems, integrating with existing testing and simulation infrastructure to find and prioritize failures and quantify safety risk. The company, which serves autonomous vehicle developers, has been acquired by Waymo.
2 investors
SPT Labtech designs and manufactures laboratory instruments and automation tools for life science research, including liquid handling systems, cryo-electron microscopy sample preparation, and automated sample storage. Its products serve scientists and researchers in genomics, protein crystallization, drug discovery, and next generation sequencing.
2 investors
TTTECH is a group of technology companies that develops networked computing and safety control systems for safe, secure, and autonomous machine operations. Its products serve industries including aviation, space, mobile and industrial machinery, automotive, and energy, with a focus on the Industrial Internet of Things and software-defined machines.
2 investors
Tune Insight develops privacy-preserving data collaboration software that combines homomorphic encryption, secure multiparty computation, differential privacy, and federated learning, allowing organizations to derive insights without directly sharing or manipulating raw data. Founded out of EPFL's Laboratory for Data Security in 2021, it focuses initially on the health and medical research sector.
2 investors
Type One Ventures is a multi-stage venture capital firm that invests in founders building space technologies, AI and automation, robotics, mobility, nanotechnology, and human longevity. It backs companies developing the infrastructure and industrial systems aimed at advancing humanity toward an interplanetary future.
2 investors
Type6 Therapeutics is a drug-discovery company developing kinase inhibitors that target the inactive OFF-state of kinases to improve selectivity and durability against cancers that evade existing therapies. Its lead program is a CDK2 inhibitor (CDK2i), with plans to expand into additional kinase targets across the human kinome.
2 investors
Umbra is a U.S.-based space technology company that designs, builds, and operates advanced satellite systems for remote sensing and mission-critical solutions, delivering synthetic aperture radar (SAR) imagery and custom capabilities.
2 investors
UnaBiz designs and manufactures IoT sensors and provides cloud platform services across low-power wide-area technologies including Sigfox, LTE-M, NB-IoT and LoRa. It serves clients in verticals such as smart metering, smart facilities management, and smart logistics and supply chain.
2 investors
Understand.ai provides AI, scenario engineering, data management, and simulation expertise to support the development and validation of autonomous systems from initial concept through production, operating as part of the dSPACE technology group.
2 investors
Uniquesec develops radar target simulation technology for testing automotive radar systems in the lab under realistic conditions. Its patented ASGARD systems use frequency-domain and MIMO-based angular simulation to emulate radar reflections and virtual targets for evaluating radar performance, availability, and reliability.
2 investors
Unit1 Studio produces virtual concerts and avatar-based live performances, creating digital doubles of artists and combining LED display, lighting, sound, and post-production technologies for stage and screen. It works with entertainment industry partners to build virtual stages and live show experiences.
2 investors
UNLIMITED provides an AI-powered platform for engineering and delivering physical infrastructure projects, helping small teams accelerate work and align project outcomes. The platform is designed for domain experts in industries like energy, hydrogen, mining, and infrastructure development.
2 investors
Unseenlabs operates a satellite constellation that detects and geolocates radio frequency (RF) signals emitted by ships, enabling the tracking of uncooperative "dark vessels" that evade traditional surveillance. It provides RF geolocation data, timestamps, and intelligence reports for maritime monitoring, serving governments and private companies managing territorial waters and assets at sea.
2 investors
Unternet is building an intelligent computer along with an open software ecosystem to power it, including Web Applets (an open standard for taking actions on the web), Kernel (a runtime for intelligent software), and Tabletop (a natural computer interface). The company operates in the AI and developer software space.
2 investors
Until develops reversible cryopreservation systems for human donor organs, translating cryobiology into engineered workflows across perfusion, cryoprotectants, cooling, rewarming, and organ-health assessment. The technology aims to prevent ice formation during vitrification and address the donor organ procurement and matching problem.
2 investors











